Business ❯ Pharmaceutical Industry ❯ Manufacturing

Quality Control

Product Safety Product Recalls Regulatory Compliance Product Recall Sresan Pharma Product Liability Substandard Products Supply Chain Management Inspection Reports Export Regulations Product Bans Packaging Errors FDA Regulations Licensing Issues Ascend Laboratories Inspection Procedures

FDA Eases CMC Rules for Cell and Gene Therapies to Speed Development

The move aligns oversight with the realities of small‑batch, personalized products to address serious unmet needs.

Teva, Amerisource Pull 580,000+ Prazosin Bottles as FDA Flags Nitrosamine Contamination

Ascend Recalls 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures